Stephen D. Mcmurray serves as Executive at MEDGENICS, INC., where they oversee executive responsibilities. Since joining the company, Stephen D. Mcmurray has executed 8 insider transactions totaling $146.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 1, 2014 involved purchasing 2,439 shares valued at $10.0K.
Stephen D. Mcmurray currently holds 96,274 shares of MEDGENICS, INC. (MDGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen D. Mcmurray has been a net seller of MDGN stock. They have purchased $10.0K and sold $136.7K worth of shares.
Stephen D. Mcmurray's most recent insider trade was on Dec 1, 2014, when they purchased 2,439 shares at $4.10 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 2, 2013 | MDGN | $0 | Award | 7,000 | $N/A | Discretionary |
| Aug 24, 2012 | MDGN | $136.7K | Sale | 10,935 | $12.50 | Discretionary |
| Aug 17, 2012 | MDGN | $242.8K | Payment | 22,117 | $10.98 | Discretionary |
| Aug 17, 2012 | MDGN | $242.9K | Option Exercise | 33,052 | $7.35 | Discretionary |
| Jan 3, 2012 | MDGN | $0 | Award | 7,000 | $N/A | Discretionary |
| Apr 13, 2011 | MDGN | $0 | Conversion | 1,840 | $N/A | Discretionary |